PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Chart, page-3433

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    Whilst I get your point and want to focus in on what's holding sentiment back, here is an interesting perspective from CSL boss Paul Perreault on lessons learned:

    Perreault says that he never tried to be a salesman for CSL shares like he had seen some other CEOs do. “I was doing our road shows and we had a break. One analyst came in and said: ‘So why should we buy the shares?’ I said: ‘If you have to ask me that question, don’t buy them’. “He said: ‘But you’re the CEO.’ I said: ‘Yeah, my job is not to sell you stock. If you want to talk about the strategy, the portfolio, where we are headed and you like what you hear then please buy the stock. But if not, I’ve got plenty of shareholders.’ He was shocked and said: ‘I’ve never heard a CEO say that’. “If you do the right things for the business, for the patients, the values and culture of the organisation and if you have something meaningful to deliver then things should work out ok.”
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.